Cargando…
Voriconazole-induced Severe Hyperkalemia Precipitated by Multiple Drug Interactions
Voriconazole, a triazole antifungal agent used to treat serious fungal infections, has a pharmacokinetic characteristic of undergoing hepatic metabolism by the cytochrome P450 system. Few cases of hyperkalemia have been reported, which presented only when the serum voriconazole level was exceptional...
Autores principales: | Choi, Jae Young, Cho, Seong Geun, Jang, Ki-Seok, Kim, Gheun-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte Metabolism
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327389/ https://www.ncbi.nlm.nih.gov/pubmed/32655651 http://dx.doi.org/10.5049/EBP.2020.18.1.10 |
Ejemplares similares
-
Severe secondary hyperkalemia and arrhythmia from drug interactions between calcium‐channel blocker and voriconazole: a case presentation
por: Zhao, Xinju, et al.
Publicado: (2021) -
Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
por: Kim, Gheun-Ho
Publicado: (2019) -
Pharmacokinetic Drug Interaction between Tofacitinib and Voriconazole in Rats
por: Lee, Ji-Sang, et al.
Publicado: (2021) -
Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients
por: Yu, Mi-Yeon, et al.
Publicado: (2017) -
Hyperkalemia and severe rhabdomyolysis
por: Mugmon, Marc
Publicado: (2011)